↓ Skip to main content

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes

Overview of attention for article published in Cochrane database of systematic reviews, November 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter
4 tweeters

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes
Published in
Cochrane database of systematic reviews, November 2013
DOI 10.1002/14651858.cd002130.pub4
Pubmed ID
Authors

Bosch X, Marrugat J, Sanchis J, Bosch, Xavier, Marrugat, Jaume, Sanchis, Juan

Abstract

During percutaneous coronary intervention (PCI), and in non-ST segment elevation acute coronary syndromes (NSTEACS), the risk of acute vessel occlusion by thrombosis is high. Glycoprotein IIb/IIIa blockers strongly inhibit platelet aggregation and may prevent mortality and myocardial infarction. This is an update of a Cochrane review first published in 2001, and previously updated in 2007 and 2010.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Germany 2 2%
Brazil 1 <1%
Denmark 1 <1%
Colombia 1 <1%
Unknown 104 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 14%
Student > Bachelor 15 14%
Student > Master 15 14%
Student > Ph. D. Student 10 9%
Other 7 6%
Other 20 18%
Unknown 28 25%
Readers by discipline Count As %
Medicine and Dentistry 50 45%
Nursing and Health Professions 11 10%
Social Sciences 6 5%
Psychology 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 10 9%
Unknown 27 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2020.
All research outputs
#8,979,799
of 16,276,732 outputs
Outputs from Cochrane database of systematic reviews
#9,037
of 11,462 outputs
Outputs of similar age
#110,114
of 256,163 outputs
Outputs of similar age from Cochrane database of systematic reviews
#130
of 171 outputs
Altmetric has tracked 16,276,732 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,462 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.1. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 256,163 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 171 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.